<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>BMC Microbiology                                                                                                                         BioMed Central <br />  <br />  <br />  <br /> Research article                                                                                                                       Open Access <br /> Gene disruption DNA topoisomerase IB small subunit <br /> induces non-viable phenotype hemoflagellate Leishmania <br /> major <br /> Rafael Bala&#195;&#177;a-Fouce*, Carlos Garc&#195;&#173;a-Estrada, Yolanda P&#195;&#169;rez-Pertejo Rosa M Reguera <br />  <br /> Address: Departamento Farmacolog&#195;&#173;a y Toxicolog&#195;&#173;a (INTOXCAL), Universidad Le&#195;&#179;n, Campus Vegazana s/n; 24071 Le&#195;&#179;n, Spain <br /> Email: Rafael Bala&#195;&#177;a-Fouce* - rbalf@unileon.es; Carlos Garc&#195;&#173;a-Estrada - c.gestrada@unileon.es; Yolanda P&#195;&#169;rez-Pertejo - myperp@unileon.es; <br /> Rosa M Reguera - rmregt@unileon.es <br /> * Corresponding author <br />  <br />  <br />  <br />  <br /> Published: 8 July 2008                                                         Received: 5 February 2008 <br />                                                                                Accepted: 8 July 2008 <br /> BMC Microbiology 2008, 8:113   doi:10.1186/1471-2180-8-113 article available  http://www.biomedcentral.com/1471-2180/8/113 <br /> &#194;&#169; 2008 Bala&#195;&#177;a-Fouce et al; licensee BioMed Central  Open Access article distributed terms Creative Commons Attribution License (http://creativecommons.org/licenses 2.0), permits unrestricted use, distribution, reproduction medium, provided original work properly cited. <br />  <br />  <br />  <br />  <br />                  Abstract <br />                  Background: unusual heterodimeric leishmanial DNA topoisomerase IB consists large <br />                  subunit containing phylogenetically conserved &quot;core&quot; domain, small subunit harboring                  C-terminal region characteristic tyrosine residue active site. RNAi silencing                  protomers induces non-viable phenotype hemoflagelate Trypanosoma brucei. <br />                  Unfortunately, approach suitable Leishmania gene replacement                  antibiotic marker approach generate lack function mutants. work,                  successfully generated null mutants small subunit L. major DNA topoisomerase IB using <br />                  selection markers, conferring resistance hygromycin B puromycin, respectively. <br />                  Results: successfully replaced topS loci selection markers.                   achieve second transfection round, rescue null-homozygous                  episomal vector carrying Leishmania major topS gene. Phenotypic characterization L. major <br />                  rescued strain L. major strain, overexpresses subunits, shows differences <br />                  DNA relaxation camptothecin cytotoxicity compared wild-type strain. <br />                  Studies <span id='am-5' about='obo:IMR_0001358' typeof='owl:Thing obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-6' property="oboInOwl:hasAlternativeId" content="IMR:0200250" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasExactSynonym" content="O-Phosphatidyl-L-serine" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="KEGG:C02737" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="O-Phosphatidyl-L-serine" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="CHEBI:18303" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="phosphatidylserine" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0001358" datatype="xsd:string"></span>phosphatidylserine</span> externalization poor incidence camptothecin-induced <br />                  programmed cell death L. major, effective cell-cycle arrest occurs 24 h. S- <br />                  Phase delay G2/M reversible arrest main outcome lower concentrations,                  irreversible G2 arrest detected higher camptothecin pressure. <br />                  Conclusion: Results obtained work evidence essentiality topS gene encoding                  L. major DNA topoisomerase IB small subunit. Reversibility camptothecin effect points                  existence effective checkpoint mechanisms Leishmania parasites. <br />  <br />  <br />  <br />  <br /> Background                                                                      mosquito&apos;s bite-place [1]. existing line therapies <br /> Leishmania major aetiological agent cutaneous                         based pentavalent antimonium salts antiquated <br /> leishmaniasis, zoonotic neglected tropical disease char-                      toxic [2]. Paromomycin-based ointments triazole <br /> acterized presence ulcerative skin lesions                     antifungal agents (fluconazole, itrakonazole ketoco- <br />  <br />  <br />                                                                                                                                        Page 1 14 <br />                                                                                                                  (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                               http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br /> nazole) variable limited efficacy [3]     somes treated specific inhibitor camptothecin <br /> clinical trials carried promising alkyl-phos-     (CPT) [18]. <br /> pholipid miltefosine [4] scarce. recent report <br /> carried Iran concluded oral miltefosine        Inhibitors DNA topoisomerases represent major class <br /> apparently good pentavalent antimonium salts         anti-cancer drugs growing number treatment L. major cutaneous leishmaniasis [5].         clinical use [19]. studies shown CPT                                                                strong anti-trypanosomal anti-leishmanial activities scenario urgent need new antileish-    vitro, inducing DNA-cleavable complexes sub- <br /> manial drug targets. DNA topoisomerases   catalyze         micromolar range [20]. outcome stable DNA cleav- <br /> changes superhelicity duplex DNA repli-       age generation single- double-stranded breaks, <br /> cation, transcription, recombination DNA repair            believed cause point mutations, fragmenta- <br /> processes [6,7]. families subfamilies DNA       tion genome eventually programmed cell death <br /> topoisomerases play pivotal role preserving DNA integ-       (PCD) [21]. <br /> rity living organisms. Type (TopI) <span id='am-38' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-39' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-44' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span>ATP</span>- <br /> independent monomeric enzymes introducing transient            mechanism RNAi-mediated gene attenua- <br /> single-stranded breaks DNA, followed passage         tion functional Leishmania parasites [22], gen- <br /> rejoining. Type II (TopII) multimeric ATP hydro-       eration null-mutants feasible gene <br /> lyzing proteins generate temporary double-stranded        replacement techniques warranty total disruption <br /> breaks double helix, followed passage            target gene. present work describes pheno- <br /> rejoining. TopII relaxes positively supercoiled       type null-mutant small subunit L. major <br /> DNA, displays catenation/decatenation knot-       TopIB, sensitivity CPT PCD induced ting/unknotting activities. TopIA subfamily produces           inhibitor aetiological agent cutaneous leish- <br /> transient covalent bonds 5&apos; end broken DNA,      maniasis L. major. TopIB subfamily specific cleavage polarity 3&apos; end [8].                                             Results <br />                                                                Double targeted gene replacement LmTopS <br /> Unlike organisms studied present, TopIB        asses biological involvement LmTopIB relax- <br /> trypanosomes leishmanias heterodimeric                 ation supercoiled DNA CPT susceptibility, tried <br /> enzymes [9-11]. Genetic analyses identified gene,            create null-mutant knockout topS locus dou- <br /> located L. donovani chromosome 34,                ble-targeted replacement antibiotic resistant cassettes <br /> encodes large subunit (LdTopIL) estimated            [23], kindly provided S.M. Beverley (Uni- <br /> molecular mass 73 kDa. protein contains       versity Washington St. Louis, Mo USA). topS <br /> non-conserved N-terminus conserved cen-         gene encodes catalytic active site LmTopIB, tral core domain enzyme, includes res-    effective disruption gene nullify biolog- <br /> idues interact DNA, DNA-cleaving          ical function entire enzyme. purpose, tyrosine. hand, small subunit (LdTopIS)       created targeting plasmids pSK-topS-KO-HYG encoded second ORF located chromosome 4.            pSK-topS-KO-PAC. contain respective antibiotic ORF encodes 262-long polypeptide pre-            resistance cassettes flanked 1000-bp region dicted molecular mass 28-kDa. polypeptide          includes 5&apos; 3&apos; flanking regions topS <br /> tains phylogenetically conserved &quot;SKxxY&quot; motif,            gene (Fig. 1A).  topS-allele replaced HYG- includes Tyr-222 plays role DNA cleav-     resistance cassette create heterozygous strain <br /> age. [12]. genomic organization confirmed soon        (&#206;&#8221;topS::HYG). Hybridization external probe (EP) African trypanosomes [13] genes encod-        shows 1.7-kb XhoI fragment present genomic <br /> ing TopIB protomer annotated T.          DNA WT promastigotes additional 2.6-kb <br /> cruzi Genome Project [14].                                     fragment corresponding effective allele replace- <br />                                                                ment. Colonies isolated heterozygous strain eukaryotic cells, TopIB TopII essential     perfectly viable used perform second cell life [15,16]. Enzyme silencing T. brucei TopII   replacement round. strain electroporated <br /> small RNA interference (RNAi) produces singular phe-         lineal pSK-topS-KO-PAC create homozygous <br /> notype lacking kDNA, called dyskinetoplasticy leads       (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC), set double resistant HYG/ cell death [17]. Furthermore, RNAi-mediated silencing       PAC colonies obtained (clones 1 5), gene expression subunit TopIB results       able growth antibiotics selective pressure. South- <br /> drastic reduction DNA RNA synthesis Afri-       ern analysis isolated clones shows trypanosomes, mimicking inhibition nucleic          predicted 2.6 kb corresponding allele replace- <br /> acid biosynthesis observed bloodstream trypano-           ment, second 2.2 kb-long band corresponding  <br />  <br />                                                                                                                    Page 2 14 <br />                                                                                              (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                               http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                                             1.7 kb XhoI           0.7 kb XhoI <br />                                                                               X <br />                                                             X                          X <br />                                                                 EP <br />                                                                      UST topS DST <br />  <br />                                                                      X                            0.5 kb <br />                                                                                   EV <br />  <br />  <br />  <br />  <br />                                                                                     double genetic replacement <br />  <br />  <br />                                                                          2.6 kb <br />                                                             X                          X <br />                                                                 EP <br />  <br />                                                                           HYG <br />                                                                                                   0.5 kb <br />  <br />                                                                          2.2 kb <br />                                                             X                          X <br />                                                                 EP <br />                                                                           PAC <br />                                                                                                   0.5 kb <br />  <br />  <br />  <br />          External probe (EP)                                                               topS probe <br />                                       topS/ topS        topS/ topS+topS                                    topS/ topS          topS/ topS+topS <br />                       WT    (+/-) 1     2   3   4   5   1   2    3 4      5                WT   (+/-) 1     2     3   4    5   1    2    3 4    5 <br />               4.0 <br />               3.0 <br />  <br />               2.0 <br />    topS       1.5 <br />  <br />  <br />  <br />  <br /> Figure   1 <br /> Construction   L. major topS-null mutants (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC), double targeted gene replacement <br /> Construction L. major topS-null mutants (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC), double targeted gene replacement.  Strategy tar- <br /> geted gene replacement. (Upper) topS gene locus, location upstream (UST) downstream (DST) segments <br /> used target homologous recombination 1.7-kb XbaI restriction fragments. disruption constructs shown imme- <br /> diately  including UST DST fragments, XbaI EcoRV terminal polylinker restriction sites. targeted <br /> gene replacement event indicated arrow, showing structure resulting chromosomal locus predicted 2.6-kb 2.2-kb XbaI restriction fragments diagnostic correct homologous integration events. X, <br /> indicate XbaI restriction sites. Generation null-mutant required second targeted gene replacement using similar gene <br /> disruption cassette containing PAC marker. B) Southern blot containing 10 &#206;&#188;g genomic DNA WT parasites, hetero- <br /> zygous knockout line integration HYG gene disruption construct (+/-), (&#206;&#8221;topS/&#206;&#8221;topS) integration PAC, (&#206;&#8221;topS/&#206;&#8221;topS+topS integration PAC clone previously transfected episomal vector pXG-topS carry- <br /> ing topS genehybridized radiolabeled probe represented white box located outside disruption region <br /> (external probe, EP). C) blot shown B elution EP rehybridization topS probe. numbers <br /> indicate positions sizes (kb pairs) DNA molecular weight markers. <br />  <br />  <br /> second gene substitution, present (Fig. 1B).                   pXG-topS construct, episomal plasmid expresses 1.7-kb XhoI fragment, hybridizes EP,                    topS presence DHFR/TS locus L. remains, showing unexpected trisomy topS                   major. new strain used second replace- <br /> locus clones 1, 3, 4 5. remove band, het-               ment. circumstances 1.7-kb band effec- <br /> erozygous (&#206;&#8221;topS::HYG) clone transfected                      tively disappeared isolated clones showing  <br />  <br />                                                                                                                                         Page 3 14 <br />                                                                                                                 (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  2.2 2.6-kb expected bands. correspond       obtained (Fig. 5) leishmanial strains. WT <br /> correct homologous integrations upstream               strain showed slower active relaxation activity <br /> stream topS locus. Southern analysis clones     (Fig. 4A). substrate relaxed different <br /> obtained experiments using topS gene         topoisomers perceptible supercoiled DNA probe, shows effective replacement topS        remained 20 min higher protein concentra- <br /> alleles (lanes 8 12 Figure 1C), addition   tion. relaxation activity strains intense 3 kb band corresponding episomal topS            faster higher shown control. Figure <br /> gene required complement topoisomerase defi-             4B shows fully relaxed DNA 5 min LmTopIB- <br /> ciency. clone representing new L. major strain         overexpressing strain, 4-fold higher activity (com- called (&#206;&#8221;topS/&#206;&#8221;topS) + topS indicating rescued          paring lane 3 set B lane 1 set . null-topS genotype.                                             LmTopIB-overexpressing strain compared                                                                 rescued (&#206;&#8221;topS/&#206;&#8221;topS) + topS knockout (Fig. 4C), differ- <br /> Western analyses WT, (&#206;&#8221;topS/&#206;&#8221;topS) + topS              ences time protein dilution observed. LmTopIB overexpressing strains carried assess       remarkable scarce differences relaxation expression rate TopIB genes. purpose,       activity strains accordance lack heterologous LdTopIL LdTopIS polyclonal rabbit              significant differences CPT cytotoxicity. <br /> antisera used hybridize transferred pro- <br /> teins SDS-PAGE. Figure 2A shows results               determine phase cell cycle CPT <br /> obtained hybridization LdTopIL antiserum,            exerts growth inhibitory effect, exponentially growing evidences significant 7-fold increase immu-      L. major promastigotes treated different concen- <br /> noreactive band corresponding LmTopIB-overex-            trations CPT 24 h analyzed flow cytometry. <br /> pressing strain. Figure 2B shows similar Western blot,        Submicromolar concentrations CPT did appear case nylon membrane hybridized         exert effect. significant 51% S-phase arrest <br /> LdTopIS rabbit antiserum, showing ca. 7-fold overex-          appeared treatment 1 &#206;&#188;M CPT (&#206;&#8221;topS/ <br /> pression small subunit, LmTopIB-overex-          &#206;&#8221;topS) + topS strain, increased 64% pressing (&#206;&#8221;topS/&#206;&#8221;topS) + topS extracts.                     presence 50 &#206;&#188;M CPT (Fig. 5). <br />  <br /> Phenotypic characterization genetically manipulated L.       determine CPT-induced S-phase arrest <br /> major strains                                                   reversible, L. major promastigotes treated 24 h phenotypic outcome genetic manipulation topS          induce S-phase arrest. CPT washed locus evaluated rescued (&#206;&#8221;topS/&#206;&#8221;topS) + topS,        cells incubated fresh medium addi- <br /> LmTopIB overexpressing WT L. major strains.             tional period 24 h (R24) 48 h (R48). CPT-treated WT <br /> growth rate strains analyzed 96 h         cells able revert cell-growth arrest lower <br /> span-time, 12 h stepwise, presence different      drug concentration (5 &#206;&#188;M) 24 h, arrest centrations CPT (0.5 25 &#206;&#188;M). proliferation rate       irreversible 50 &#206;&#188;M CPT 48 h drug  measured cell counting (Fig. 3A&#226;&#8364;&#8220;C) using Coul-         drawal (Fig. 6A). case LmTopIB-overexpressing ter apparatus. significant differences growth rate        rescued-mutant (&#206;&#8221;topS/&#206;&#8221;topS) + topS strains, CPT induced noticed strains study.           irreversible S-phase arrest concentration tested <br /> higher growth WT promastigotes          (Figs. 6B 6C). genetic manipulation exerted strains, probably continuous antibiotic      Progression cell cycle <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="chemical" datatype="xsd:string"></span>chemical</span> synchroniza- <br /> selection pressure exerted culture medium main-       tion studied L. major promastigotes <br /> tain strains. CPT equally effective        strains. use 5 mM HU, inhibitor ribonucle- <br /> strains; dose-response curves determined 48 h sub-        otide reductase, reversibly arrest DNA synthesis, passages provided IC50 values 0.56 &#206;&#188;M, 0.39 &#206;&#188;M           previously reported [24]. 12-h exposure 0.30 &#206;&#188;M WT, (&#206;&#8221;topS/&#206;&#8221;topS) + topS LmTopIB           HU, percentages L. major promastigotes dif- <br /> expressing strains, respectively.                               ferent cell cycle phases  65% G1, 23% S                                                                 12% G2/M. Promastigotes underwent cell cycle progres- evaluate topoisomerase activity displayed       sion HU removal, time required com- <br /> leishmanial strains, standard relaxation assays        plete cell cycle dependent genetic <br /> formed WT, (&#206;&#8221;topS/&#206;&#8221;topS) + topS LmTopIB           manipulation carried topS locus.  WT <br /> expressing lysates coming log-phase cultures. Time-        phenotype needs 24 h complete cell cycle; time <br /> course (left lanes) lysate dilution (right lanes) experi-   longer LmTopIB-overexpressing strain, <br /> ments carried 37&#194;&#176;C. experimental        rescued-mutant (&#206;&#8221;topS/&#206;&#8221;topS) + topS com- <br /> conditions clear distributive relaxation pattern          pleted cell-cycle progression shorter period 9 h. <br />  <br />  <br />                                                                                                                     Page 4 14 <br />                                                                                               (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                                       http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />                                                                                        PCD 24 h, extended incubation period 48 <br />  <br />  <br />  <br />  <br />                        LmTopIB overexpresing <br />                                                                                        h using 10 &#206;&#188;M CPT. Apoptosis assessed time <br />  <br />  <br />  <br />  <br />                                                ( topS/ topS) + topS <br />                                                                                        (Fig. 9). Surprisingly, significant differences                                                                                        observed strains. results indicate                                                                                        CPT inducing PCD L. major cultures                                                                                        experimental conditions using lab. <br />  <br />                                                                                        Discussion <br />                                                                                        Double targeted gene replacement method choice <br />                                                                                        create defective null-mutants Leishmania parasites <br />              WT <br />  <br />  <br />  <br />  <br />                                                                                        [22]. L. major TopIB-null mutant defective small <br />                                                                       hybridized    subunit enzyme  contains DNA-cleaving <br />                                                                                        tyrosine) created assess role played                                                                     anti-topL        enzyme parasite survival CPT resistance.                                                                                        colonies obtained repeatedly second round                                                                                        replacement, suspected gene essential Leish- <br />                                                                                        mania activity    B                                                                  anti-topS        enzymes. outcome incomplete replacement                                                                                        LmTopIB alleles selectable antibiotics                                                                                        emergence trisomies topS locus (lanes 1, 3, 4                                                                       anti- -actin     5, Fig. 1), non-atypical phenomenon kineto- <br />    C                                                                                   plastids plasticity genome [25]. <br />                                                                                         decided perform previous transforma- <br /> rum <br /> LdTopIS <br /> Figure <br /> WT,   B)  2 <br /> Expression <br /> hybridizing <br /> cuedWestern <br />         Similar <br />      strain analysis <br />                          polyclonal <br />             ofusing <br />                 LmTopIB measuring <br />      LmTopIB-overexpressing <br />                    heterologous <br />                      aAheterologous <br />                        antiserum <br />                         butunder <br />                             hybridizing <br />                                  &#206;&#178;-actin <br />                                                                    different <br />                                    TopIL <br />                                  C)      topolyclonal <br />                                       Similar <br />                                         (&#206;&#8221;topS/&#206;&#8221;topS) <br />                                      LdTopIL                                                  protein <br />                                             agenetic    +BtopS <br />                                               heterologous <br />                                                topolyclonal <br />                                                      abundance <br />                                                       antiserum <br />                                                                                                                   manipulations <br />                                                             antise- <br />                                                                res-                    tion plasmid carrying target gene episomal <br /> Expression LmTopIB different genetic manipulations                            expression genetic complementation sec-  Western analysis measuring TopIL protein abundance                               ond round genomic replacement. case, suc- <br /> WT, LmTopIB-overexpressing (&#206;&#8221;topS/&#206;&#8221;topS) + topS res- <br />                                                                                        cessfully obtained colonies, topS <br /> cued strain, using heterologous LdTopIL polyclonal antise- <br /> rum B) Similar hybridizing heterologous                                  allele replaced antibiotic marker. Essentiality <br /> LdTopIS polyclonal antiserum C) Similar B                                 TopIB described Drosophila [15] mouse <br /> hybridizing heterologous &#206;&#178;-actin polyclonal antiserum.                            [16], outcome TopIB gene disruption                                                                                        dead phenotype. budding yeast remarkable excep- <br />                                                                                        tion phenomenon [26]. S. cerevisiae-deficient effects independent CPT treatment,                                 TopIB viable currently used important <br /> strongly suggest, genetic manip-                             tool gene expression foreign recombinant TopIB, <br /> ulation strains (Fig. 7).                                                       expression enzymes bacteria dif- <br />                                                                                        ficult feasible. <br /> Quantification PS externalization L. major <br /> promastigotes                                                                          Gene silencing TbTopIL TbTopIS genes carried measure CPT-induced PCD L. major, FACS pro-                               Bakshi Shapiro [18] using RNAi. authors <br /> cedure carried combining PI/annexin V double                                   indistinct phenotypes separately silenced <br /> stain. Promastigotes cultured presence different                            TbTopIL TbTopIS genes; detectable reduction ribos- <br /> concentrations CPT different time-points                             omal RNA levels specific messengers, optimal conditions PCD. Figure 8 shows trans-                              growth arrest, decrease total nucleic acid biosynthesis <br /> location PS outer surface plasma membrane                              attributable reductions DNA- RNA-specific <br /> drug-treated promastigotes 0.1 &#206;&#188;M, 0.5 &#206;&#188;M, 1 &#206;&#188;M, 5 &#206;&#188;M                               synthesis. Absolute levels nuclear mitochondrial 10 &#206;&#188;M CPT. L. major strains used                                  transcripts reduced. L. major single replace- <br /> study incubated different CPT concentrations                                 ment alleles originated heterozygous phe- period 24 h submitted                                notype differentiable WT cell double stain protocol. Panels slight increase                            growth CPT sensitivity. <br /> early late apoptosis  upper-right sections panel, respectively) regarding untreated cul-                              promastigotes genetically rescued <br /> tures, barely rose CPT concentration.                                  topS-null mutant ones TopIB overexpressing <br /> effect studied (&#206;&#8221;topS/&#206;&#8221;topS) + topS                                strain, showed different growth rates significant IC50 <br /> LmTopIB-overexpressing strains, scarcely increased                               values CPT. unexpected results correlated parameter. CPT did significantly induce                                 relaxation activities extracts <br />  <br />  <br />                                                                                                                                           Page 5 14 <br />                                                                                                                     (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                                           http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                        50                                                  coordinated expression subunits neces- <br />                                                                                            sary African trypanosomes. RNAi silencing                                                 WT <br />  Cell growtn, promastigotes x 106/ml <br />  <br />  <br />  <br />  <br />                                                                                          TbTopIB protomers causes coordinated loss                                        40 <br />                                                                                            subunits [18]. authors speculated individual <br />                                                                                            proteins stable association  <br />                                        30                                                  unstable separated. <br />  <br />                                        20                                                  reports conclude TopIB overexpression does <br />                                                                                            involve higher relaxation activity CPT susceptibility <br />                                                                                            mammalian cells [27]. recent paper describing                                        10 <br />                                                                                            transfection human TopIB gene OVCAR-3 cultures <br />                                                                                            &#226;&#8364;&#8220; ovarian cancer cell line &#226;&#8364;&#8220; shows  despite effec- <br />                                         0                                                  tive seven-fold TopIB overexpression, sensitivity                                                                                            topotecan &#226;&#8364;&#8220; CPT hydrosoluble analogue &#226;&#8364;&#8220;                                                                                        B   improved compared control untransfected cells [28]. <br />  Cell growtn, promastigotes x 106/ml <br />  <br />  <br />  <br />  <br />                                        30       ( topS/ topS)+topS <br />                                                                                            observation agrees similar levels TopIB <br />                                        25                                                  activity control overexpressing cells, point- <br />                                                                                            ing effective post-translational regulation <br />                                        20 <br />                                                                                            mechanism limiting TopIB activity supportable <br />                                        15                                                  values. authors tempted speculate                                                                                            TopIB overexpression produces alteration phos- <br />                                        10                                                  phorylation state protein limits activity                                                                                            prevents improvement CPT response [29,30].                                         5                                                  likely dispensable 40 amino acids-long sequence <br />                                         0 <br />                                                                                            comprised Ser-96 Ser-135 N-ter- <br />                                                                                            minal extension LmTopIB small subunit  <br />                                        30 <br />                                                 LmTopIB overexpressing                 C   tains 27 serine residues [31,32], suitable  Cell growtn, promastigotes x 106/ml <br />  <br />  <br />  <br />  <br />                                                                                            phosphorylation/dephosphorylation processes act- <br />                                        25                                                  ing post-translational switch mechanism. <br />                                        20 <br />                                                                                            CPT toxicity depends ability DNA repair systems <br />                                        15                                                  restore basic cellular functions. TopIB overexpres- <br />                                                                                            sion trigger repair mechanisms linked                                        10                                                  enzyme tyrosyl diphosphodiesterase (TdpI), <br />                                                                                            prevents formation ternary complexes                                        5                                                   DNA presence CPT ubiquitination/ <br />                                                                                            sumoylation pathways [33]. Ubiquitination  <br />                                        0 <br />                                                                                            regulation mechanism takes place hyper- <br />                                             0        20     40        60        80   100   phosphorylated enzyme. TopIB degradation 26S pro- <br />                                                                  Time (hours) <br />                                                                                            teasome useful increase tolerance DNA- <br />                                                                                            cleaving poisons, facilitating phosphodiesterase activ- <br /> &#206;&#8221; <br /> Figure <br /> strain   3   topS+topS) <br />        (C)  tostrain <br /> Sensibility    L  (B) <br />                    major WTand <br />                      specific TopIB <br />                                , <br />                                                                   LmTopIB <br />                                     inhibitor <br />                                        rescued  (&#206;&#8221;topS/ <br />                                               CPT <br />                                               overexpresing <br /> Sensibility L. major WT  , rescued (&#206;&#8221;topS/                                        ity Tdp1 excise Top1 cleaved DNA [34]. &#206;&#8221;topS+topS) strain (B) LmTopIB overexpresing                                       hand, sumoylation stimulatory strain (C) specific TopIB inhibitor CPT. Cell density                               relocation TopIB nucleoplasm nucleo- monitored growing concentrations: (m) control; (t)                                  lus preventing ubiquitin-mediated enzyme degrada- <br /> 0.125 &#206;&#188;M; (l) 0.25 &#206;&#188;M; (&#208;&#338;) 0.5 &#206;&#188;M; (n) 1 &#206;&#188;M; (h) 5 &#206;&#188;M                                  tion [35]. <br /> -25 (&#194;&#353;) &#206;&#188;M CPT Coulter. Experiments carried triplicate error bars represent standard deviations.                                Flow-cytometric analysis 12 h HU-arrested L. major pro- <br />                                                                                            mastigotes shows different cell-cycle recovering pattern <br />                                                                                            drug withdrawal. LmTopIB-overexpressing strain <br /> obtained different strains, scarce differ-                                  shows S-phase delay cell cycle, fully <br /> ences accounted. likely explanation                                  completed 24 h chemical arrest. contrary, ing possible degradation overexpressed                                       rescued-mutant (&#206;&#8221;topS/&#206;&#8221;topS) + topS completes cell <br /> subunit, unless assembled large subunit                                     cycle shorter period 9 h, hours WT. <br /> building active enzyme. evidences showing                                     Synchronized L. major promastigotes exposed dif- <br />  <br />  <br />                                                                                                                                                Page 6 14 <br />                                                                                                                          (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                               http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                                                              described CPT-mediated leishmanicidal effect L. <br />                                       Time (min)                               donovani promastigotes appears mitochondrial <br />                                   0.5 1   5 10 15 20   1   2   3   4   5   6   function inhibited, turn followed                 WT       N-                                                    increase mitochondrial membrane potential.                          R <br />                                                                                authors showed CPT increases intracellular  <br />                                                                                centration reactive oxygen species (ROS),  <br />                          S- <br />                                                                                comitant rise <span id='am-20' about='obo:IMR_0001362' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-21' property="rdfs:label" content="lipid" datatype="xsd:string"></span><span id='am-22' property="obo:IAO_0000115" content="Organic molecule that is insoluble in water but tends to dissolve in nonpolar organic solvent." datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasDbXref" content="CHEBI:25054" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:id" content="IMR:0001362" datatype="xsd:string"></span>lipid</span> peroxidation decline                                                                                concentration free radical scavenger <span id='am-26' about='obo:IMR_0100173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001700'><span id='am-27' property="rdfs:label" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-28' property="obo:IAO_0000115" content="A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides." datatype="xsd:string"></span><span id='am-29' property="oboInOwl:id" content="IMR:0100173" datatype="xsd:string"></span><span id='am-30' property="rdfs:label" content="L-Glutathione" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasExactSynonym" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasExactSynonym" content="L-Glutathione" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="glutathione" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasExactSynonym" content="Reduced glutathione" datatype="xsd:string"></span>glutathione</span>.                                       Time (min) <br />                                                                                second report, authors described involvement <br />                      B <br />                                   0.5 1   5 10 15 20 <br />                                                                                caspase-3 poly-(<span id='am-14' about='obo:IMR_0001360' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-15' property="oboInOwl:hasDbXref" content="KEGG:C00008" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasAlternativeId" content="IMR:0200375" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:id" content="IMR:0001360" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="ADP" datatype="xsd:string"></span>ADP</span>-ribose) polymerase (PARP) <br />                                                        1   2   3   4   5   6 <br /> LmTopIB overexpressing N - <br />                                                                                cleavage CPT-mediated apoptosis depletion                                                                                intracellular K+ DNA fragmentation, time <br />                          R                                                     span [40]. results reproducible L. major <br />                                                                                promastigotes assay conditions expressed                          S- <br />                                                                                Materials Methods. Expanded time points  <br />                                                                                centrations able produce effects described <br />                                       Time (min)                               authors. Unlike aforementioned results, <br />                      C            0.5 1   5 10 15 20   1   2   3   4   5   6   50% apoptosis early <br />     topS/ topS) + topS <br />                              N-                                                4-h exposure 5 &#206;&#188;M CPT, detect &#226;&#8364;&#8220; using <br />                                                                                PS/PI double stain assay &#226;&#8364;&#8220; scant 12% apoptosis                          R <br />                                                                                48 h exposure CPT. According current knowledge <br />                                                                                trypanosomatids genome, apoptosis pathway <br />                              S- <br />                                                                                described authors downstream CPT-induced ROS <br />                                                                                production, unlikely. genes involved cas- <br /> genetically <br /> DNA <br /> Figurerelaxation <br />         4 manipulated <br />                  activityatofthe <br />                               thetopS <br />                                   L. major <br />                                       locusWT strain <br /> DNA relaxation activity L. major WT strain                      pase cascade PARP cleavage annotated genetically manipulated topS locus. 0.2 Micrograms                   Leishmania genome Project metacaspase-like <br /> leishmanial extracts incubated 0.125 &#206;&#188;g RfI                       proteins recently described responsible cas- <br /> &#206;&#166;X174 supercoiled DNA 30 min 37&#194;&#176;C. Lanes 1 6                         pase-like activities PCD [37,41]. Time concentra- <br /> correspond time-course experiments (0.5, 1, 5, 10, 15, 20                   tion experiments showed episomal <br /> min). Lanes 7 12 correspond fold serial dilution                   overexpression complete LmTopIB poor <br /> assay leishmanial extracts.  WT; B) LmTopIB-overex-                       impact CPT-mediated L. major apoptosis. results <br /> presing strain; C) (&#206;&#8221;topS/&#206;&#8221;topS) + topS strain; N, nicked plas-                disagree previous experiments carried COS <br /> mid; R, relaxed plasmids; S, supercoiled plasmids.                             cells transfected yeast topIB encoding gene <br />                                                                                (ScTopIB), CPT treatment resulted preferential <br />                                                                                killing apoptosis cells expressing yeast <br /> ferent concentrations CPT period 24 h                     enzyme &quot;mock&quot; transfected cells [42]. washed incubated 48 h CPT-free                        possible explanation differences consist medium. differences detected dis-                          high differences relaxation activity (ca. 100-fold) <br /> tinct strains CPT concentrations submicromolar                        produced transient transfection ScTopIB gene range.  1 &#206;&#188;M CPT produced S-phase delay WT                          COS cells. (&#206;&#8221;topS/&#206;&#8221;topS) + topS strains reversible G2 arrest 5 &#206;&#188;M CPT. constant pressure  24 h) following                         Conclusion <br /> CPT removal induces activation S-phase check-                        topS gene essential L. major survival, point mammalian cells. Checkpoint activation pro-                           previous genetic rescue episomal plasmid carrying <br /> vides additional time DNA repair starting new                     topS gene necessary obtain complete double <br /> cell cycle [36]. hours 5 &#206;&#188;M CPT removal                      replacement topS alleles. Rescued (&#206;&#8221;topS/&#206;&#8221;topS) + <br /> results complete recovery cell cycle WT pro-                    topS LmTopIB-overexpressing strains charac- <br /> mastigotes, large percentage (&#206;&#8221;topS/&#206;&#8221;topS) + topS                     teristic phenotype relaxation activity CPT      LmTopIB-overexpressing       promastigotes                      resistance. lack phenotype post- <br /> remained arrested G2/M phase.  50 &#206;&#188;M CPT                            translational modifications threshold produced clear irreversible arrest G2/M                      needed alter function reached.  <br /> strains analyzed.                                                               CPT treatment subsequent removal produced                                                                                recovery arrested cell-cycle G2/M, Like DNA damaging agents, CPT efficient                            delayed overexpressing strain. poor CPT- <br /> inducer PCD [37,38]. Sen coworkers [39]                            induced PCD observed L. major promastigote <br />  <br />  <br />                                                                                                                                   Page 7 14 <br />                                                                                                             (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                  http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                      0                20 nM               1 M                 5 M                   50 M <br />  <br />  <br />              WT <br />  <br />  <br />  <br />  <br /> LmTopIB-overexpressing <br />  <br />  <br />  <br />  <br />   ( topS/ topS) + topS <br />  <br />  <br />  <br />  <br /> FACS <br /> Figureanalysis <br />         5       cell cycle progression CPT-induced growth arrest L. major promastigotes <br /> FACS analysis cell cycle progression CPT-induced growth arrest L. major promastigotes. Dose-response effect CPT-inducing cellular arrest. Fluorescence intensity representing cellular DNA content shown X axis, cell <br /> count shown Y axis. total 20,000 events collected FACS analysis. left-hand peak panel repre- <br /> sents G1 cells, right-hand peak represents G2 cells points  represent S-phase cells. Exponential growing <br /> cultures treated indicated concentrations CPT 24 h (T24). drug removal  rinsing cultures drug-free medium), cells incubated fresh medium 24 hours (R24) 48 hours (R48). Cells collected time point, DNA content analyzed. <br />  <br />  <br /> strains suggests alternative cytotoxic mechanisms          Genome Database [43]. resulting fragment previously shown L. donovani.                      digested SmaI BamHI cloned expres- <br />                                                                  sion vector pXG [44] make pXG-topS. integrity Methods                                                          plasmid confirmed sequencing. <br /> Parasite cultures <br /> L. major LV39c5 promastigotes (WT strain) cultured          topS deletion constructs created: pSK-topS-KO- 26&#194;&#176;C M199 supplemented 10% (v/v) heat-inac-           HYG pSK-topS-KO-PAC. topS ORF upstream <br /> tivated fetal calf serum (FCS).                                  (UST) downstream (DST) sequences (1.0 kb  <br />                                                                  amplified PCR using primers incorporated <br /> Drug solutions                                                   restriction sites suitable subsequent insertion CPT (Sigma Chemical  St. Louis USA) dissolved          polylinker region pSK Bluescript (Stratagene) vector <br /> dimethylsulfoxide (DMSO) 20 mM final concentration            &quot;head tail&quot; manner. DNA fragments corre- stored -20&#194;&#176;C.                                             sponding hygromycine B (HYG) puromycin (PAC) <br />                                                                  selection antibiotics based Leishmania expres- <br /> Cloning LdTopS LdTopL genes molecular                 sion vector series pXG-HYG pXG-PAC [45]. HYG constructs                                                       PAC ORFs obtained digestion BamHI gene encoding catalytic subunit LmTopIB (topS         SpeI cloned UST DST sequences 789-bp fragment) amplified PCR L. major            topS ORF. resulting constructs (pSK-topS-KO- <br /> genomic DNA using primers 5&apos;-tcccccgggccaccAT-               HYG, pSK-topS-KO-PAC) digested NotI- <br /> GCAGCCTGTTCAAAGTCCT-3&apos;,                    5&apos;-cgcggatcct-    EcoRV obtain linear topS deletion fragments (3.0 kb caaaaatcgaagttctcggc-3&apos; (capitalized letters topS).     HYG-cassette 2.6 kb PAC-cassette, respectively). <br /> Sequence primers extracted L. major <br />  <br />  <br />                                                                                                                      Page 8 14 <br />                                                                                                (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                            http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                                                 WT <br />                                     0 <br />  <br />  <br />  <br />  <br />                                    5 M <br />  <br />  <br />  <br />  <br />                                    50 M <br />  <br />  <br />  <br />                                               T24              R24             R48 <br />  <br />  <br />                                B                           LmTopIB-overexpressing <br />                                         0 <br />  <br />  <br />  <br />  <br />                                     5 M <br />  <br />  <br />  <br />  <br />                                     50 M <br />  <br />  <br />  <br />                                                 T24            T24            R48 <br />  <br />  <br />                                C <br />                                         0                        ( topS/ topS) + topS <br />  <br />  <br />  <br />  <br />                                     5 M <br />  <br />  <br />  <br />  <br />                                     50 M <br />  <br />  <br />  <br />                                                 T24             R24             R48 <br />  <br />  <br /> Figure same6 experiment shown figure 5 performed experiment shown figure 5 performed. B) WT; C) LmTopIB-overexpressing strain D) rescued <br /> (&#206;&#8221;topS/&#206;&#8221;topS) + topS strain. Cells collected time point, DNA content analyzed. <br />  <br />  <br />  <br />  <br />                                                                                                               Page 9 14 <br />                                                                                         (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                  http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />             WT               Reference              7               9               11              14                   24 h <br />           0 CPT <br />  <br />  <br />  <br />  <br />            WT <br />          5 M CPT <br />  <br />  <br />  <br />  <br />     LmTopIB-overexpressing <br />             0 CPT <br />  <br />  <br />  <br />  <br />     LmTopIB-overexpressing <br />           5 M CPT <br />  <br />  <br />  <br />  <br />     ( topS/ topS) +topS <br />            0 CPT <br />  <br />  <br />  <br />  <br />     ( topS/ topS) +topS <br />          5 M CPT <br />  <br />  <br />  <br />  <br /> Figure 7of DNA content L. major promastigotes reversible arrest HU <br /> Analysis <br /> Analysis DNA content L. major promastigotes reversible arrest HU. Cells obtained 12 h-arrest 5 mM <br /> HU (time 0) harvested incubated fresh media presence absence 5 &#206;&#188;M CPT. time periods indi- <br /> cated, cells stained propidium iodide (PI) analyzed flow-cytometry. graphs represent relative PI fluo- <br /> rescence plotted frequency events channel. plot represents data collected 20,000 events/sample. <br />  <br />  <br />  <br /> LmTopL encoding gene corresponds large DNA-               cytomix (120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4, <br /> binding subunit leishmanial TopIB. amplified           25 mM Hepes pH 7.6, 2 mM EDTA, 5 mM MgCl2) [46] L. major genomic DNA using oligonucleotides 5&apos;-         resuspended solution concentration <br /> tcccccgggccaccATGAAGGTGGAGAATAGCAAGATG-3&apos;                        1 &#195;&#8212; 108 promastigotes ml. microliter 5&apos;-cgcggatccCTACACCCTCAAAGCTGCAAGAGG-3&apos;                      aliquots electroporated twice 5 &#206;&#188;g linear <br /> (capitalized letters topL). resulting fragment      3.0-kb NotI-EcoRV topS::HYG fragment (1.5 kV, 25 &#206;&#188;F digested SmaI-BamHI cloned                 using Bio-Rad Gene Pulser II apparatus) 0.4 cm elec- <br /> expression vector pXG-HYG, constituting plas-           trode gap cuvettes, transferred 10 ml M199 plus 10% <br /> mid pXG-HYG-topL. overexpressing LmTopIB strain               FCS incubated 26&#194;&#176;C 8 h absence antibiot- obtained double transformation pXG-topS              ics. Cells spun  pellet resuspended pXG-HYG-topL.                                                100 &#206;&#188;l fresh M199 plus 10% FCS plated sem- <br />                                                                  isolid medium containing 30 &#206;&#188;g/ml HYG. Heterozygotes <br /> Deletion L. major topS gene                               showing replacement alleles topS (+/-) order replace topS allele, L. major WT promastig-    subjected second round gene disruption. <br /> otes, grown 5 &#195;&#8212; 106 ml, washed cold            purpose, electroporated 5 &#206;&#188;g  <br />  <br />                                                                                                                     Page 10 14 <br />                                                                                                (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                 http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                          untreated   CPT 0.1 M                CPT 1 M               CPT 5 M                 CPT 10 M <br />        WT <br />  LmTopIB-overexpressig <br />   ( topS/ topS) + topS <br />  <br />  <br />  <br />  <br /> Figure  treated <br />         8     PS externalization different concentrations <br />                       consequence  CPTofexposure; <br />                                                CPT WT, <br />                                                        24 h analyzed PCD <br />                                                             LmTopIB-overexpressing rescued (&#206;&#8221;topS/&#206;&#8221;topS)+topS strains <br /> PS externalization consequence CPT exposure; WT, LmTopIB-overexpressing rescued (&#206;&#8221;topS/&#206;&#8221;topS)+topS strains treated different concentrations CPT 24 h analyzed PCD. Dead cells excluded PI incorpora- <br /> tion. Dot plots representative independent assays. <br />  <br />  2.6-kb NotI-EcoRV topS::PAC fragment. clones            ml HYG, 10 &#206;&#188;g/ml G418 30 &#206;&#188;g/ml PAC selected <br /> (topS-1&#226;&#8364;&#8220;5) grew presence 30 &#206;&#188;g/ml HYG         rescued topS-null mutants (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC) + <br /> 30 &#206;&#188;g/ml PAC selected topS-null mutants                  topS,  strain called: (&#206;&#8221;topS/&#206;&#8221;topS) + topS (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC). Successful integration          , episomal plasmid pXG-topS. <br /> cassettes achieved clones.   replacement topS alleles incomplete      SDS-PAGE Western Blotting clones.                                                  L. major promastigotes harvested different times <br />                                                                  growth washed twice PBS. soni- new approach double gene replacement car-         cation centrifugation 10,000 &#195;&#8212; g 20 min, ried using topS heterozygous clones, trans-       supernatant removed. micrograms protein <br /> fected pXG-topS. clones resistant        time point diluted loading buffer <br /> 30 &#206;&#188;g/ml HYG 10 &#206;&#188;g/ml G418 selected                 (60 mM Tris-HCl, pH 6.8, 2% SDS, 5% 2-mercaptoetha- <br /> named (-/+)/+ topS. new clone used perform           nol, 5% glycerol), boiled 5 min, analyzed second round gene disruption. Electroporation         SDS-PAGE (12% acrylamide, 2.7% bisacrylamide). Pro- <br /> performed 5 &#206;&#188;g 2.6-kb NotI-EcoRV topS::PAC           teins electrotransferred PVDF membranes <br /> fragment. clones grew presence 30 &#206;&#188;g/        (Sigma) 12 h 25&#226;&#8364;&#8220;30 V/cm, blots  <br />  <br />                                                                                                                    Page 11 14 <br />                                                                                               (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                       http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                                                                    Time (hours) <br />  <br />                                                    24 <br />                                                    24                                   36 <br />                                                                                         36                                              48 <br />                                                                                                                                         48 <br />                            untreated <br />  wt <br />   LmTopIB-overexpressing <br />   ( TopS/ TopS) +topS <br />  <br />  <br />  <br />  <br /> Figure 9 <br /> Time-course  experiment PS externalization CPT exposure <br /> Time-course experiment PS externalization CPT exposure. WT, LmTopIB-overexpressing rescued (&#206;&#8221;topS/ <br /> &#206;&#8221;topS)+topS strains exposed 5 &#206;&#188;M CPT treatment 24, 36 48 h. PS externalization monitored FACS. <br /> Dead cells excluded PI incorporation. Dot plots representative independent assays. <br />  <br />  <br /> blocked incubation 10 mM Tris-HCl, pH 7.5, 1 M            manial lysates. reaction contained 125 ng super- <br /> NaCl, 0.5% Tween 20, 5% non-fat milk powder (w/v)           coiled close circular DNA virus &#206;&#166; X-174 (Rf  1 h room temperature. Polyclonal primary rabbit anti-        20 &#206;&#188;l reaction buffer (100 mM KCl, 10 mM Tris-HCl, <br /> bodies L. donovani large LdTopIL, small LdTopIS <br /> subunits &#206;&#178;-actin added buffer            Platting cells <br />                                                                     24 hr <br />                                                                                                                         7   9 11   14        24 hr <br /> blot incubated 2 h. filter washed thor-                                            12 hr   2 hr <br />  <br /> oughly 10 mM Tris-HCl, pH 7.5, 1 M NaCl, 0.5%                                                  HU 5mM <br /> Tween 20 incubated anti-rabbit anti-                                                             5    M CPT <br />                                                                                                                       75 min <br /> body conjugated horseradish peroxidase (Sigma Chem- <br /> ical  St. Louis USA). Antibodies detected using                                                Reference <br /> 3,3&apos;-diamino benzidine substrate (Biorad). <br />                                                                 Figure <br />                                                                 Scheme <br />                                                                 CPT treatment <br />                                                                        10 <br />                                                                        culture synchronization 5 mM HU Assays TopIB-mediated relaxation plasmid DNA             Scheme culture synchronization 5 mM HU relaxation activity LmTopIB assayed           CPT treatment. <br /> indicated time points using 2-fold serial dilutions leish- <br />  <br />  <br />                                                                                                                                    Page 12 14 <br />                                                                                                       (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                  http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br /> pH 7.5, 1 mM DTT, 1 mM EDTA). reactions               Authors&apos; contributions <br /> incubated 37&#194;&#176;C 20 min stopped           RBF RMR conceived study, participated addition 5 &#206;&#188;l 5 &#195;&#8212; stop buffer (2.5% SDS, 25 mM           design performed deletion complementation <br /> EDTA, 25% Ficoll 400, 0.08% bromophenol blue, 0.08%            LmTopS gene. YPP CGE participated  <br /> xylene). products analyzed electrophoresis      struction plasmids performed phenotypical <br /> 1% agarose gel, stained ethidium bromide, visu-       analyses. RBF, CGE, YPP RMR drafted manuscript <br /> alized UV transilluminator.                             RMR revised article. authors read                                                                approved final manuscript. <br /> Flow-cytometric analysis DNA content flow-cytometric analysis, 4 &#195;&#8212; 106 promastigotes       Acknowledgements <br /> harvested centrifugation 660 &#195;&#8212; g, washed twice      research partially supported MEC (grant AGL2006-07420/ <br /> PBS, resuspended 1 ml fixative solution (30% PBS/        GAN) Instituto Salud Carlos III (grant PI06302 RICET) 70% methanol) incubated 4&#194;&#176;C 1 h.         Ministerio Salud y Consumo Spanish Kingdom. <br /> parasites collected centrifugation, resuspended PBS containing 20 &#206;&#188;g/ml RNaseA (Roche, Mannheim,            References <br />                                                                1.    Bailey M, Lockwood DN: Cutaneous leishmaniasis. Clin Dermatol <br /> Germany) incubated 20 min 37&#194;&#176;C. incu-               2007, 25:203-211. <br /> bation, cells harvested, resuspended 1 ml       2.    Bala&#195;&#177;a-Fouce R, Cubr&#195;&#173;a JC, Reguera RM, Ord&#195;&#179;&#195;&#177;ez D: pharma- <br />                                                                      cology leishmaniasis. Gen Pharmacol 1998, 30:435-443. <br /> citrate buffer (45 mM MgCl2, 30 mM sodium citrate, 20          3.    Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker <br /> mM Mops, pH 7.0, 0.1% Triton X-100), stained                  S: Cutaneous leishmaniasis. Lancet Infect Dis 2007, 7:581-596. addition 50 &#206;&#188;g propidium iodide (PI) (Sigma, St.     4.    Berman J: Clinical status agents developed leish- <br />                                                                      maniasis. Expert Opin Invest Drugs 2005, 14:1337-1346. <br /> Louis, MO, U.S ) followed incubation 37&#194;&#176;C 20       5.    Mohebali M, Fotouhi  Hooshmand B, Zarei  Akhoundi B, Rah- <br /> min. Fluorescence determined flow cytometry                nema  Razaghian AR, Kabir MJ, Nadim  Comparison milte- FACSCalibur flow cytometer (Becton Dickinson, San                 fosine meglumine antimoniate treatment                                                                      zoonotic cutaneous leishmaniasis (ZCL) randomized <br /> Jose, CA, U.S ).                                                   clinical trial Iran. Acta Trop 2007, 103:33-40. <br />                                                                6.    Champoux JJ: DNA topoisomerases: Structure, function,                                                                      mechanism. Ann Rev Biochem 2001, 70:369-413. <br /> Cell cycle synchronization CPT treatment                   7.    Wang JC: Cellular roles DNA topoisomerases: molecular synchronization DNA replication, exponen-                 perspective. Nat Rev Mol Cell Biol 2002, 3:430-440. <br /> tially growing L. major promastigotes (5 &#195;&#8212; 106 cells/ml)       8.    Corbett KD, Berger JM: Structure, molecular mechanisms,                                                                      evolutionary relationships DNA topoisomerases. Ann Rev arrested 5 mM hydroxyurea (HU) 12 h.                   Biophys Biomol Struct 2004, 33:95-118. parasites harvested, washed twice         9.    Bakshi RP, Shapiro TA: DNA topoisomerases targets anti- <br />                                                                      protozoal chemotherapy. Mini Rev Med Chem 2003, 3:597-608. <br /> PBS resuspended fresh medium 2 h use.        10.   Reguera RM, Redondo CM, Gutierrez Prado R, Perez-Pertejo Y, <br /> Cells treated 5 &#206;&#188;M CPT 75 min                 Bala&#195;&#177;a-Fouce R: DNA-topoisomerase parasitic proto- <br /> finally incubated CPT-free medium time indi-            zoa: potential target chemotherapy. Biochim Biophys Acta <br />                                                                      2006, 1759:117-131. <br /> cated scheme Figure 10.                              11.   Bala&#195;&#177;a-Fouce R, Redondo CM, P&#195;&#169;rez-Pertejo Y, Diaz-Gonz&#195;&#161;lez R, <br />                                                                      Reguera RM: Targeting atypical trypanosomatid DNA topoi- <br /> Determination apoptosis                                           somerase  Drug Discov Today 2006, 11:733-740. <br />                                                                12.   Villa H, Otero-Marcos AR, Reguera RM, Bala&#195;&#177;a-Fouce R, Garc&#195;&#173;a- <br /> Apoptosis detected translocation phosphatidyl              Estrada C, P&#195;&#169;rez-Pertejo Y, Tekwani BL, Myler PJ, Stuart KD, Bjornsti <br /> serine (PS) cell surface annexin V-FITC rea-         MA, Ord&#195;&#179;&#195;&#177;ez D: novel active DNA topoisomerase Leish- <br />                                                                      mania donovani. J Biol Chem 2003, 278:3521-3526. <br /> gent (BD Pharmigen). Fraction annexin V-positive cells      13.   Bodley AL, Chakraborty AK, Xie S, Burri C, Shapiro TA: unusual measured CellQuest software (BD Biosciences,                type IB topoisomerase African trypanosomes. Proc Natl <br /> San Jose, CA).                                                       Acad Sci USA 2003, 100:7539-7544. <br />                                                                14.    [http://www.tigr.org/tdb/e2k1/tca1]. <br />                                                                15.   Lee MP, Brown SD, Chen  Hsieh TS: DNA topoisomerase List abbreviations                                                essential Drosophila melanogaster. Proc Natl Acad Sci USA <br />                                                                      1993, 90:6656-6660. <br /> Camptothecin (CPT); dimethylsulfoxide (DMSO); exter-           16.   Morham SG, Kluckman KD, Voulomanos N, Smithies O: Targeted <br /> nal probe (EP); Fluorescence Activated Cell Sorting                  disruption mouse topoisomerase gene <span id='am-54' about='obo:IMR_0100024' typeof='obo:IMR_0100022 owl:Thing obo:IMR_0001355 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-55' property="rdfs:label" content="cAMP" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:id" content="IMR:0100024" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="3&apos;,5&apos;-Cyclic AMP" datatype="xsd:string"></span><span id='am-58' property="rdfs:label" content="Adenosine 3&apos;,5&apos;-phosphate" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasExactSynonym" content="3&apos;,5&apos;-Cyclic AMP" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasExactSynonym" content="Adenosine 3&apos;,5&apos;-phosphate" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasExactSynonym" content="Cyclic AMP" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasDbXref" content="KEGG:C00575" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasAlternativeId" content="IMR:0200099" datatype="xsd:string"></span><span id='am-65' property="rdfs:label" content="Cyclic adenylic acid" datatype="xsd:string"></span><span id='am-66' property="oboInOwl:hasExactSynonym" content="Cyclic adenylic acid" datatype="xsd:string"></span><span id='am-67' property="rdfs:label" content="Cyclic AMP" datatype="xsd:string"></span>camp</span>- <br /> (FACS); Fetal Calf Serum (FCS); hydroxyurea (HU);                    tothecin selection. Mol Cell Biol 1996, 16:6804-6809. <br />                                                                17.   Wang  Englund PT: RNA interference trypanosome <br /> hygromycine B (HYG); large subunit leishmanial DNA                topoisomerase II causes progressive loss mitochondrial <br /> topoisomerase (LmTopIL); small subunit leishmanial                DNA. EMBO J 2001, 20:4674-4683. <br /> DNA topoisomerase (LmTopIS); puromycin (PAC); Poly-            18.   Bakshi RP, Shapiro TA: RNA interference Trypanosoma bru- <br />                                                                      cei topoisomerase IB: subunits essential. Mol Bio- <br /> (ADP-ribose)-polymerase (PARP); Programmed Cell                      chem Parasitol 2004, 136:249-255. <br /> Death (PCD); propidium iodide (PI); phosphatidylserine         19.   Pommier Y: Topoisomerase inhibitors: Camptothecins                         <br /> </body></html>